This product provides switching patterns between different biologic disease-modifying antirheumatic drugs (bDMARDs) during first, second, and third lines of bDMARD therapy. All patients in this dataset received treatment with adalimumab (Humira), the best-selling drug in the United States since 2012. Additional datasets and summaries – including focus on other drugs, additional lines of therapy, and specific time periods – are available upon request. For more information, visit [www.om1.com](http://www.om1.com) and get in touch at [info@om1.com](mailto:info@om1.com).
Access to weather data plays a vital role in many industries. This detailed weather file provides you with a rolling 14 days of daily historical weather information for the most common weather variables that can impact your business each and every day.
iPatientAxis is a global clinical trial and data services organization who has aggregated a diverse longitudinal database of real-world clinical EMR data of over 19 M unique patients. This robust NASH aggregate patient location by metropolitan area analysis is just one of the indications that iPA...
Rheumatoid Arthritis Disease Registry Analysis of US Population. Utilizing the iPatientAxis database of over 19,000,000 unique US patient lives, this aggregated data analysis of US based patients provides insights into assembled incidence by US state including medications and co-morbidities. All...
| Heapery Attribution License | Heapery-Private |
| Category | Health |
| Data Schema | |
| Support Contact Email Address | support@heapery.com |
| Data Format | |
| Version number | |
| Language | English |
| Data Size | |
| Last Updated Date | 8/11/2020 |
| Refund Policy | Refunds not allowed |
